VANLENT ANNE 4
4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed Dec 1, 2022
Insider Transaction Report
Form 4
VANLENT ANNE
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−10,000→ 0 totalExercise: $4.25Exp: 2028-07-25→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−12,000→ 0 totalExercise: $4.72Exp: 2030-12-16→ Common Stock (12,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−16,000→ 0 totalExercise: $15.13Exp: 2026-08-17→ Common Stock (16,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−8,000→ 0 totalExercise: $7.75Exp: 2027-02-28→ Common Stock (8,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−10,000→ 0 totalExercise: $6.90Exp: 2028-11-15→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−10,000→ 0 totalExercise: $3.02Exp: 2029-12-04→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−14,000→ 0 totalExercise: $2.17Exp: 2031-11-30→ Common Stock (14,000 underlying)
Footnotes (1)
- [F1]At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option.